Imlygic 10e6, Injektionslösung

7680658120010 CH-65812 Injektionslösung
Imlygic 10e6, Injektionslösung
Imlygic 10e6, Injektionslösung
Imlygic 10e6, Injektionslösung
1 / 3
google

Article details

Package size
1 ml
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/05/2025
Patient information leaflet
Français
08/05/2025
Patient information leaflet
Italien
08/05/2025
Summary of Product Characteristics
Allemand
08/05/2025
Summary of Product Characteristics
Français
08/05/2025
Summary of Product Characteristics
Italien
08/05/2025

Detailed composition

Substance Quantity Type Category
SOLU
- Substance Wirkstoff (Principe actif)

Reimbursement information

Public price
CHF 2233.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2017

Authorization holder

Amgen Switzerland AG

6343 Risch

Authorization information

Swissmedic authorization number
65812
Drug name
Imlygic, Injektionslösung
Galenic form
LSPA
ATC Code
L01XL02
Authorization status
Z
Dispensing category
A
First authorization
13/07/2016
Authorization expiration date
31/12/9999
IT Number
07.16.
Domain
Human medicine
Field of application
Imlygic ist zur Behandlung von Melanomen mit regionalen oder entfernten Metastasen bei Erwachsenen indiziert.

Package details

Description (FR)
IMLYGIC sol inj 1 mio UFP/ml flac 1 ml
Description (DE)
IMLYGIC Inj Lös 1 Mio PFU/ml Durchstf 1 ml
Market launch
13/07/2016
Narcotic (BTM)
No

Application methods

ILES

Other package sizes (1)

IMLYGIC sol inj 100 mio UFP/ml flac 1 ml
1 ml DUR
GTIN: 7680658120027
View